About N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide
N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide (PubChem CID 10240272) has the molecular formula C35H36ClF3N4OS
and a molecular weight of 653.21 g/mol. Its IUPAC name is N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide.
Molecular Properties
| Compound Name | N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide |
| PubChem CID | 10240272 |
| Molecular Formula | C35H36ClF3N4OS |
| Molecular Weight | 653.21 g/mol |
| Exact Mass | 652.23 |
| IUPAC Name | N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide |
| SMILES | CCCCN(Cc1nc2cc(C(F)(F)F)ccc2n1Cc1ccccc1CN1CCCCC1)C(=O)c1sc2ccccc2c1Cl |
| InChI | InChI=1S/C35H36ClF3N4OS/c1-2-3-19-42(34(44)33-32(36)27-13-7-8-14-30(27)45-33)23-31-40-28-20-26(35(37,38)39)15-16-29(28)43(31)22-25-12-6-5-11-24(25)21-41-17-9-4-10-18-41/h5-8,11-16,20H,2-4,9-10,17-19,21-23H2,1H3 |
| InChIKey | AYBKLZRWMTYSST-UHFFFAOYSA-N |
| XLogP | 9.40 |
| TPSA | 41.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 653.21 |
| LogP ≤ 5 | 9.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Analyze N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide?
The IUPAC name of N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide (CID 10240272) is N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide.
What is the SMILES notation for N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide?
The canonical SMILES for N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide is CCCCN(Cc1nc2cc(C(F)(F)F)ccc2n1Cc1ccccc1CN1CCCCC1)C(=O)c1sc2ccccc2c1Cl.
What is the InChIKey of N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide?
The InChIKey is AYBKLZRWMTYSST-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H36ClF3N4OS/c1-2-3-19-42(34(44)33-32(36)27-13-7-8-14-30(27)45-33)23-31-40-28-20-26(35(37,38)39)15-16-29(28)43(31)22-25-12-6-5-11-24(25)21-41-17-9-4-10-18-41/h5-8,11-16,20H,2-4,9-10,17-19,21-23H2,1H3.
What are the key properties of N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide?
N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide has a molecular weight of 653.21 g/mol, XLogP of 9.40, 10 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-butyl-3-chloro-N-[[1-[[2-(piperidin-1-ylmethyl)phenyl]methyl]-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-1-benzothiophene-2-carboxamide is sourced from PubChem (CID 10240272), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).